TEM

Tempus AI, Inc. (Ticker: TEM) is a leading healthcare technology company based in Chicago, Illinois, that leverages artificial intelligence and advanced data analytics to revolutionize medical decision-making and tailor treatment plans. Its comprehensive platform combines genomic sequencing with clinical data to propel precision medicine, particularly in oncology, thereby improving patient outcomes. As the healthcare landscape increasingly shifts towards technology-driven solutions, Tempus's innovative approach and dedication to transforming healthcare practices position it as a compelling investment opportunity for institutional investors looking to capitalize on growth within this rapidly evolving sector.